Abstract
Short chain dehydrogenases/reductases (SDR) constitute a large protein family. The SDR family now includes more than 1,000 enzymes from humans, mammals, insects and bacteria, and exhibits a wide variety of substrate specificity for steroids, retinoids, prostaglandins, sugars, alcohols and other small molecules. These enzymes have a residue identity level of 15-30 perent. Much has been done in the last decade to understand the structure function relationships in the SDR enzymes. This review summarizes recent progress of structural and functional studies of the enzymes belonging to the SDR family (X ray crystal structure analyses and site directed mutagenesis studies). Based on these studies, the three dimensional structure, catalytic mechanism, coenzyme specificity, and substrate specificity of the SDR enzymes are discussed.
Keywords: SDR structure, Short chain dehydrogenase, Oxidoreductase, MDR enzymes, Monomeric enzymes, Single domain protein, Rossmann fold, C terminal residues, Coenzyme binding mode, pyrophosphate moiety, active site cleft, ser tyr lys triad, deprotonated phenolic group, coenzyme specificity, Substrate specificity, membrane spainnig domain
Current Organic Chemistry
Title: SDR Structure, Mechanism of Action, and Substrate Recognition
Volume: 5 Issue: 1
Author(s): Nobutada Tanaka, Takamasa Nonaka, Kazuo T. Nakamura and Akira Hara
Affiliation:
Keywords: SDR structure, Short chain dehydrogenase, Oxidoreductase, MDR enzymes, Monomeric enzymes, Single domain protein, Rossmann fold, C terminal residues, Coenzyme binding mode, pyrophosphate moiety, active site cleft, ser tyr lys triad, deprotonated phenolic group, coenzyme specificity, Substrate specificity, membrane spainnig domain
Abstract: Short chain dehydrogenases/reductases (SDR) constitute a large protein family. The SDR family now includes more than 1,000 enzymes from humans, mammals, insects and bacteria, and exhibits a wide variety of substrate specificity for steroids, retinoids, prostaglandins, sugars, alcohols and other small molecules. These enzymes have a residue identity level of 15-30 perent. Much has been done in the last decade to understand the structure function relationships in the SDR enzymes. This review summarizes recent progress of structural and functional studies of the enzymes belonging to the SDR family (X ray crystal structure analyses and site directed mutagenesis studies). Based on these studies, the three dimensional structure, catalytic mechanism, coenzyme specificity, and substrate specificity of the SDR enzymes are discussed.
Export Options
About this article
Cite this article as:
Tanaka Nobutada, Nonaka Takamasa, Nakamura T. Kazuo and Hara Akira, SDR Structure, Mechanism of Action, and Substrate Recognition, Current Organic Chemistry 2001; 5 (1) . https://dx.doi.org/10.2174/1385272013375751
DOI https://dx.doi.org/10.2174/1385272013375751 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology Regulation of Neural Stem Cells in the Human SVZ by Trophic and Morphogenic Factors
Current Signal Transduction Therapy Reporting Rates of Yellow Fever Vaccine 17D or 17DD-Associated Serious Adverse Events in Pharmacovigilance Data Bases: Systematic Review
Current Drug Safety Editorial [Hot topic: Antiretroviral, Anti-Inflammatory and Dopaminergic Substances in the Treatment of HIV-Infection (Guest Editor: Gabriele Arendt)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Therapeutic Potential of Natural Products from Terrestrial Plants as TNF-α Antagonist
Current Topics in Medicinal Chemistry Aptamers Overview: Selection, Features and Applications
Current Topics in Medicinal Chemistry Methionine-Derived Metabolites in Apoptosis: Therapeutic Opportunities for Inhibitors of their Metabolism in Chemoresistant Cancer Cells
Current Medicinal Chemistry Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Destination Penis? Gene Therapy as a Possible Treatment for Erectile Dysfunction
Current Gene Therapy “Connecting the Dots” from Blood Brain Barrier Dysfunction to Neuroinflammation and Alzheimer’s Disease
Current Neurovascular Research Chemotherapy with si-RNA and Anti-Cancer Drugs
Current Drug Delivery How Inhaled Asbestos Causes Scarring and Cancer
Current Respiratory Medicine Reviews Inhibitors of Secretory Phospholipase A2 Group IIA
Current Medicinal Chemistry Spinal Cord Injury Changes Cytokine Transport
CNS & Neurological Disorders - Drug Targets Desirable Properties for 3rd Generation Cyclooxygenase-2 Inhibitors
Mini-Reviews in Medicinal Chemistry Dehydroepiandrosterone, Dehydroepiandrosterone Sulfate and Related Steroids: Their Role in Inflammatory, Allergic and Immunological Disorders
Current Drug Targets - Inflammation & Allergy COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry Pharmaceutical Aspects of Hemoglobin-Based Oxygen Carriers
Current Drug Delivery Antiviral Sensing in Teleost Fish
Current Pharmaceutical Design Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design